Immunization against A/H1N1 pandemic flu (2009–2010) in pediatric patients at risk. What might be the most effective strategy? The experience of an health district of Northern Italy
© Gregori et al.; licensee BioMed Central Ltd. 2012
Received: 13 September 2011
Accepted: 18 April 2012
Published: 17 May 2012
Vaccination coverage rates against pandemic flu were far below those required by Italian Public Health Authorities.
The aim of this retrospective study was to assess how the management of vaccination against pandemic flu in the Health District of Piacenza (Northern Italy) had conditioned the adherence of patients at risk to the H1N1flu immunization program.
From a population of 27.018 children aged between 6 months and 16 years, 2361 pediatric patients considered at risk according to the guidelines of the Ministry of Health were enrolled to receive pandemic flu vaccination.
by their pediatrician in his office after contacting him directly or by phone
by their pediatrician in his office or in a public Health District office with the assistance of a nurse after an appointment had been booked by patient’s parents using a dedicated free of charge phone number
by a doctor of the public Health District after an appointment had been booked as for option B
The best outcomes of population vaccination coverage for pandemic flu were achieved when patients were vaccinated with option B (44.2%). For options A and C rates coverage results were 22.8% (OR 2,69) and 24.9% (OR 2, 39) respectively.
The results of this study may be taken into account by the public health Authorities when planning the management of future immunization campaigns out of the usual vaccination schedule or in an emergency event.
KeywordsPandemic influenza Immunization strategy Pediatric patients
In Italy the vaccination schedule is usually performed by the public Health District (HD) with exception of the seasonal flu vaccination which is carried out by the General Practitioner on adults considered at risk and over 65 years of age. There is not specific vaccination program in place for children at risk of pandemic flu. This vaccination is performed either by family, hospital or public HD doctors: only in a few HDs primary care pediatricians (PCPs) are involved systematically in the vaccination program.
Vaccination coverage rates against pandemic flu were far below those required by Italian Public Health Authorities: at the end of March 2010 less than 1 million people had been vaccinated in Italy .
To achieve a fast immunization of patients at risk, healthcare workers and specially staff working in intensive care units at hospitals.
To have the availability of adequate doses of vaccine before the beginning of the vaccination campaign.
To resolve the first problem, in the HD of Piacenza PCPs were involved in carrying out vaccination of pediatric patients at risk, the same as it happened in the past 10 years for seasonal flu vaccination programs. This choice was made because PCPs result more effective in convincing parents to vaccinate their children, because of their popularity among Italian families .
The second problem was unsolvable: the lack of adequate amount of vaccine before the peak of the pandemic flu reduced the number of subjects who underwent vaccination.
Since 2000 PCPs working in the HD of Piacenza vaccinated against seasonal flu their patients after they were recognized to be at risk according to the guidelines of the Ministry of Health.
Vaccines were provided free of charge and patients were immunized between November and December every year.
Between 2000 and 2008 children at risk were enrolled in the seasonal flu vaccination program by their PCP. Parents were advised to vaccinate their children during routine visits or by consultation on the phone.
Vaccination campaign against A/ H1N1 virus ( 2009–10)
In September 2009 each PCP (30 PCPs in total) identified pediatric subjects considered at risk following the guidelines of the Ministry of Health* .
In a population of 27.018 children aged between 6 months and 16 years, 2361 pediatric patients were enrolled to receive pandemic flu vaccination (PFV).
To vaccinate patients in his office after previous appointment was taken by children’s parents on the phone or directly at the practice.
To vaccinate patients in his office or in a public HD office, with the assistance of a qualified nurse, after previous phone appointment using a dedicated free of charge phone number was booked by patients’ parents.
To delegate vaccination to a doctor of the public HD, after previous appointment using a dedicated free of charge phone number was taken by parents.
In our study 19 PCPs chose option A, 4 PCPs chose option B and 7 PCPs chose option C.
At the end of October 2009, near the beginning of vaccination campaign, the parents of children participating to the vaccination program were sent a letter signed by their PCP and agreed with the HD authorities: this letter remarked the usefulness of receiving PFV and which of the options available to perform the vaccination had been chosen by their PCP.
Anti A/H1N1 vaccine Focetria was used in pre-filled syringe 0.5 ml dose of thiomersal-free.
Written informed consent was obtained prior to vaccination. The vaccination campaign started on November 3, 2009 and ended on December 18, 2009. Statistical analysis was performed with chi-square test and O.R.
*chronic respiratory tract diseases, including asthma, bronchodysplasia, cystic fibrosis ;severe cardiovascular diseases, including congenital and acquired heart disease; diabetes mellitus and other metabolic diseases; severe liver disease and cirrhosis; kidney disease with renal failure; hematopoietic diseases and hemoglobinopathies;cancer; congenital and acquired diseases involving inadequate antibody production; immunosuppression induced by drugs therapy or HIV; chronic inflammatory intestinal diseases and malabsorption syndrome; diseases associated with an increased risk of aspiration such as neuromuscular diseases; obesity with body mass index (BMI) > 30; family member or close contact with persons at high risk for temporary or permanent contraindications for flu vaccination.
Main data about pediatric population enrolled to receiving vaccination against A/H1N1 pandemic flu in the health district of Piacenza
Primary Care Pediatricians
When PCP decided to vaccinate his patients choosing option B, children who underwent PFV vaccination were 44.2% of patients at risk.
Patients vaccinated using option A and C were 22.8% and 24.9% of total at risk respectively. The differences found were highly significant related to group B vs group A (χ2 85,63 p <0.000001; O.R. 2,69 [2,16-3,34] )and related to group B vs group C (χ2 33,1 p < 0.000001; O.R 2,39 [1,75-3,26]).
Probability to be classified as patient at risk based on group membership
Children at risk
Children without risk
According to the results of our study the involvement of PCP alone in performing PVF was not enough to maximize the adherence of patients to the vaccination program. The best coverage rate of vaccination for patients considered at risk for pandemic flu was achieved when PCP opted for option B, vaccinating patients in his office, with the assistance of a nurse, after children’s parents had booked an appointment calling a free of charge phone number (44.2%). Results achieved for patient vaccinated with option A (PCP performing vaccination alone) and C (public HD doctors performing vaccination) were similar, being 22.8% and 24.9% respectively. Authors suspect that the difference noted for vaccination coverage rates among the groups was mainly due ti two factors.
First we suggest that the availability of a dedicated free of charge phone number may have encouraged parents to book a vaccination appointment for their children because easy and quick. Second the availability of a nurse on premises likely allowed PCPs to save time and increase the number of patients immunized: nurses was actively involved in performing medical procedures and vaccinations making more efficient the activity of the pediatrician.
In our HD the vaccination coverage rate against pandemic flu (27.7%) was far lower from the years before regarding seasonal flu: in 2008 immunization coverage against seasonal flu in children at risk was 74.7% (1688/2258)(database of Piacenza HD, not published data).
PFV coverage rate was similar in France in the same target population . We suggest that the early presentation of pandemic flu and the lack of an adequate amount of vaccine doses before the beginning of the vaccination campaign, had a negative effect on the adherence of patients to the vaccination program.
In Piacenza HD vaccination program started on the 9th of November 2009 because the PFV became available only from the end of October 2009 .The highest incidence of influenza A/H1N1 was reached between the 26th of October 2009 and the 23rd of November 2009. The peak consisted of > 50 new cases/1000 persons/ week in the range 0–14 years), with a peak at 46th week of the year .
We hypothesize that some emotional factors (e.g. newspapers headlines, inaccurate or confusing informations reported by mass media, different opinions and behaviors among healthcare workers, presence of adjuvant in PFV) played a negative effect on performances of vaccination program .It was not possible to assess properly this issue because no specific questionnaire in order to investigate the reasons of their choice was proposed to parents who decided to refuse the vaccination of their children.
Some Authors in countries other than Italy reported the low acceptability of A/H1N1 vaccination due to different reasons including fear of side-effects, vaccine safety, not believing in vaccinations or specifically in flu vaccination [5–8].
Our study suggests that coverage levels of vaccination against pandemic flu in children at risk in Piacenza HD could be considered satisfactory (27.7%) when compared to results obtained in other groups of patients in Italy. The vaccination coverage rate achieved in Italy for severely preterm infants younger than 2 years was 7.7% and for people at risk between the ages of 6 months to 65 years was 12.7% . Another question arises about why PCPs who opted for option B enrolled a significantly higher number of patients at risk (13.6%, see Table 2). One possible explanation could be that the criteria used in selecting children at risk were not uniform among group A, B and C especially concerning asthma, the most frequent chronic disease of pediatric patients in Italy.
Being the prevalence of lifetime asthma 9.3% in italian children and 10.3% in adolescents  and considering that in Piacenza HD the prevalence of asthma is similar (9.5%)  we hypothesize that PCPs of group A enrolled less patiets for PFV (8.9%) because they chose strict selection criteria at the time of enrolling patients,especially with regards to asthma. This may have happened because, arranging appointments and performing vaccinations on their own, these PCPs were concerned about having an excessive work load and being unable to manage it successfully. It is possible that also PCPs who decided to not vaccinate personally their patients (option C) have used stricter selection criteria to include in the vaccination program patients with asthma and they were more reluctant to book their patients for PFV performed by a public HD doctor (only 5.4% of patients at risk).
We were unable to fully answer these questions because of the lack of data. Studies on this topics would be needed.
Our retrospective study suggests that the presence of PCP, nursing support staff and the availability of a dedicated free of charge phone line for booking vaccination appointments seems to ensure the best outcomes for achieving a wider coverage immunization against pandemic flu in pediatric patients.
The pandemic flu is a public health issue priority and therefore public health experts play an essential role . They have the responsibility to evaluate the impact of public health interventions in the short and long term, taking into account the human and economic resources available, the ethical aspects of the individual and the society.
The results of our study may be considered by Public Health Authorities at the time of planning the management of immunization campaigns, especially in an emergency event or when these are not part of the usual vaccination schedule.
To the primary care pediatricians of Health District of Piacenza Armani P MD, Balduzzi P MD, Boccellari R MD, Boiardi G MD, Boselli E MD, Cataldi R MD, Cervi M MD, Chitti D MD, Corna M MD, De Muru G MD, Ferrari C MD, Ferzetti A MD, Folli F MD, Fragnito C MD, Galli A MD, Ghisoni M MD, Lenzini S MD, Libè MP MD, Marenghi C MD, Marzolini R MD, Righi O MD, Rizzi L MD, Salami P MD, Suzzani L MD, Touchi F MD, Turni A MD, Zanasi P MD, Zanolli L MD.
- Greco L: Un miracolo solo italiano: una sanità di qualità a costo da saldi. Il Medico Pediatra. 2002, 6: 443-448.Google Scholar
- Ministry of Health: Misure urgenti in materia di profilassi vaccinale dell’influenza pandemica A(H1N1). Ordinanza 11 settembre 2009,http://www.normativasanitaria.it/jsp,Google Scholar
- Tuppin P, Samson S, Weill A, Ricordeau P, Allemand H: Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009. Vaccine. 2011, 29: 4632-4637. 10.1016/j.vaccine.2011.04.064.View ArticlePubMedGoogle Scholar
- Lau JTF, Yeung NCY, Choi KC, Cheng MYM, Tsui HY, Griffiths S: Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey. BMJ. 2009, 339: b4164-10.1136/bmj.b4164.PubMed CentralView ArticlePubMedGoogle Scholar
- Eastwood K, Durrheim DN, Jones A, Butler M: Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public. The Medical Journal of Australia. 2010, 192: 33-36.PubMedGoogle Scholar
- Goodwin R, Haque S, Neto F, Myers LB: Initial psychological responses to Influenza A,H1N1 (“Swine flu”). BMC Infect Dis. 2009, 9: 166-10.1186/1471-2334-9-166.PubMed CentralView ArticlePubMedGoogle Scholar
- Zijtregtop EA, Wilshut J, Koelma N, Van Delden JJ, Stolk RP, Van Steenbergen Broer J: Which factors are important in adults’ uptake of a (pre)pandemic influenza vaccine ?. Vaccine. 2009, 28 (1): 207-227. 10.1016/j.vaccine.2009.09.099.View ArticlePubMedGoogle Scholar
- Sestini P, De Sario M, Bugiani M, Bisanti L, Giannella G, Kaisermann D, Gruppo Collaborativo SIDRIA 2: Frequency of asthma and allergies in Italian children and adolescents: results from SIDRIA-2. Epidemiol Prev. 2005, 29 (2 Suppl): 24-31.PubMedGoogle Scholar
- Sacchetti R, Gregori G, Righi O, Armani P, Balduzzi P, Boccellari R: Il bambino e l’inquinamento atmosferico: la percezione del problema da parte dei genitori nella provincia di Piacenza. Medico e Bambino. 2004, 6: 399-400.Google Scholar
- Kass NE, Otto J, O’Brien D, Minson M: Ethics and severe pandemic influenza: maintaining essential functions through a fair and considered response. Biosecu Bioterror. 2008, 6 (3): 227-236. 10.1089/bsp.2008.0020.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.